4//SEC Filing
Tate Michael Truett 4
Accession 0001736297-25-000102
CIK 0001736297other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 5:10 PM ET
Size
17.8 KB
Accession
0001736297-25-000102
Insider Transaction Report
Form 4
Tate Michael Truett
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-07$170.34/sh−7,550$1,286,064→ 568,262 total(indirect: By Trust) - Sale
Common Stock
2025-08-07$173.82/sh−34,125$5,931,724→ 518,996 total(indirect: By Trust) - Gift
Common Stock
2025-08-08−10,000→ 501,496 total(indirect: By Trust) - Gift
Common Stock
2025-08-07−7,500→ 511,496 total(indirect: By Trust) - Sale
Common Stock
2025-08-07$171.48/sh−15,141$2,596,345→ 553,121 total(indirect: By Trust) - Sale
Common Stock
2025-08-07$169.61/sh−43,184$7,324,352→ 575,812 total(indirect: By Trust) - Gift
Common Stock
2025-08-07+7,500→ 7,500 total(indirect: GlobalStar DAF)
Holdings
- 278,373
Common Stock
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]Represents a bona fide gift of shares to GlobalStar DAF.
- [F7]These shares are directly owned by the GlobalStar DAF, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F8]Represents a bona fide gift of shares to a non-affiliated person.
Documents
Issuer
Astera Labs, Inc.
CIK 0001736297
Entity typeother
Related Parties
1- filerCIK 0001399546
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 5:10 PM ET
- Size
- 17.8 KB